Fauci: It's too soon to say whether Omicron will hasten pandemic's end

Experts are looking into COVID's crystal ball to predict where the Omicron variant will lead the U.S., but the picture is far from clear.
White House medical adviser Anthony Fauci said Monday that it's "an open question" whether Omicron will be the last variant wave to majorly disrupt regular life, reports CNBC. Asked whether the highly transmissible variant could spread widely enough to hasten the end of the pandemic, Fauci said, "I would hope that that's the case. But that would only be the case if we don't get another variant that eludes the immune response of the prior variant."
Pfizer CEO Albert Bourla, meanwhile, predicted a "return to normal life" sometime in the spring, reports Fox Business, citing an interview with French newspaper Le Figaro. Bourla argues COVID-19 antiviral drugs in development could work alongside vaccines to prevent severe disease. Separately, Moderna CEO Stéphane Bancel said the company's combined COVID-19 and flu shot could roll out by fall 2023, per CNN.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Other experts, like London School of Hygiene and Tropical Medicine's Annelies Wilder-Smith, say it's "too early" to call COVID endemic, but predict "there is a high probability that we will have a new variant" before then, though it would likely be less severe.
Regardless of the murky post-Omicron pandemic, all agree that while still in the grips of the current variant, we should first focus on getting through our more immediate future. Surgeon General Vivek Murthy warned Sunday that this record-setting wave has not yet peaked, and declared "the next few weeks will be tough."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
What to do if your phone is stolen
The Explainer An average of 180 phones is stolen every day in London, the 'phone-snatching capital of Europe'
By Felicity Capon Published
-
Inventive toppings for Pancake Day
The Week Recommends Ditch the maple syrup for rhubarb, marshmallow or something savoury
By Irenie Forshaw, The Week UK Published
-
Is the body positivity era over?
Talking Point For some, a 'parade of skeletons' on the red carpet is a symptom of a return to an ultra-skinny ideal
By Chas Newkey-Burden, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published